- JP-listed companies
- K Pharma,Inc.
K Pharma,Inc.JP:4896
Market cap
¥8.6B
P/E ratio
Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | |
Cash and deposits | - | 189 | 1,337 | 3,266 |
Raw materials and supplies | - | 10 | 10 | 11 |
Prepaid expenses | - | 6 | 22 | 31 |
Other | - | - | 1 | 0 |
Current assets | - | 205 | 1,371 | 3,309 |
Deposits | - | 1 | 4 | 5 |
Investments and other assets | - | 1 | 4 | 5 |
Non-current assets | - | 1 | 4 | 5 |
Assets | - | 206 | 1,375 | 3,314 |
Accounts payable - trade | - | 3 | 10 | 12 |
Accrued expenses | - | 18 | 22 | 30 |
Accounts payable - other | - | - | - | 7 |
Income taxes payable | - | 1 | 2 | 70 |
Deposits received | - | 2 | 0 | - |
Other | - | - | - | 60 |
Current liabilities | - | 23 | 34 | 178 |
Asset retirement obligations | - | 4 | 5 | 31 |
Non-current liabilities | - | 4 | 5 | 31 |
Liabilities | - | 27 | 38 | 209 |
Share capital | - | 100 | 100 | 854 |
Legal capital surplus | - | 500 | 1,275 | 2,029 |
Other capital surplus | - | 200 | 975 | 975 |
Capital surplus | - | 699 | 2,249 | 3,003 |
Retained earnings brought forward | - | -621 | -1,013 | -753 |
Retained earnings | - | -621 | -1,013 | -753 |
Shareholders' equity | - | 179 | 1,336 | 3,105 |
Net assets | 8 | 179 | 1,336 | 3,105 |
Liabilities and net assets | - | 206 | 1,375 | 3,314 |